Stay updated with Eskag Pharma’s latest formulations and insights into pharma industry trends through concise and informative blogs and articles.
Key Takeaways Distinct Roles: API manufacturing creates the raw active chemical, while formulation pharma turns that chemical into a safe, consumable ...
Building a probiotic supplement brand is far more technical than most nutraceutical brand owners anticipate, and strain viability is where that techni...
Bringing a medicine to market is far more complex than most pharma brand owners anticipate, and the formulation stage is where that complexity becomes...
Choosing the wrong pharmaceutical manufacturing partner does not just affect your margins; it puts patient safety, regulatory standing, and your brand...
Key Takeaways Evolution of Delivery: The traditional manufacturing process of vitamin c is being replaced by liposomal technology to dramatically incr...
Quality failures in the supplement industry are rarely dramatic. They usually arise from inadequate stability data, poorly validated analytical method...
Key Takeaways Business Model: Partnering with probiotics private label manufacturers allows brands to bypass the high costs of building specialized cl...
India’s nutraceutical sector has evolved into a commercially robust category, where formulation quality and regulatory credibility are key diffe...
Key Takeaways High Bioavailability: Liposomal technology ensures that liposomal iron absorption is significantly higher than traditional iron salts du...
Developing a nutraceutical product that meets quality and regulatory expectations often presents practical and technical challenges. Managing complian...
As a pharmaceutical manufacturer, you often face complex export requirements that demand precision, consistency, and strict regulatory alignment acros...
You already know that manufacturing decisions can shape your margins, timelines, and regulatory standing long before your product reaches the market. ...